1887

oa SA Pharmaceutical Journal - Vimovo® : fixed-dose naproxen/esomeprazole to treat arthritic symptoms : drug info - new product focus

 

Abstract

Vimovo® tablets contain 500 mg naproxen and 20 mg esomeprazole. The product is indicated for symptomatic relief in the treatment of osteoarthritis, rheumatoid arthritis and ankylosing spondylitis in patients needing proton-pump inhibitors (PPIs) to reduce the risk of developing nonsteroidal anti-inflammatory drug (NSAID)-associated gastric and/or duodenal ulcers.

Loading

Article metrics loading...

/content/mp_sapj/80/9/EJC144409
2013-10-01
2016-12-04
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error